PubMed Health⌕ Search

PubMed · 2692041

Male sexual dysfunction.

Abstract

Impotence and premature ejaculation are common male sexual dysfunctions that are present in most adult primary care populations. New information about the vascular and neurophysiologic mechanisms of impotence have been joined by new technology to advance the medical practices in the diagnosing and treating of the impotent male. While similar advances have not occurred in the understanding of premature ejaculation, behavior therapy techniques are extremely effective with motivated couples. Primary care physicians can aid male patients with sexual dysfunction by attempting to identify them, initiating diagnostic and treatment programs, and referring patients for additional evaluations or specialized procedures when indicated.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C C Stine, M Collins. 1989. Male sexual dysfunction.. https://pubmed.ncbi.nlm.nih.gov/2692041/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Efficacy of sildenafil citrate in treatment of erectile dysfunction: impact of associated premature ejaculation and low desire.

OBJECTIVES: To assess the effect of premature ejaculation (PE) and low desire on the efficacy and satisfaction rate of sildenafil in the treatment of erectile dysfunction (ED). METHODS: A total of 586 male patients with ED in association with and without PE or low desire were enrolled in this study. Patients were screened for ED using the International Index for Erectile Function. All patients were also screened for PE and low desire. We compared the responses to the erectile function domain, questions 3 and 4, before and after sildenafil in patients with and without PE or low desire. Overall satisfaction and global efficacy question responses were also assessed in all patients. RESULTS: The mean age +/- SD was 58 +/- 6.4 years. Significant associations were found between the increased duration and severity of ED and the decreased rate of overall satisfaction. Before sildenafil administration, significant differences were found in the erectile function domain, Q3 and Q4 between patients with and without PE or low desire. After sildenafil administration, no significant differences were found in those assessment variables and the presence or absence of PE and low desire. No significant differences were found between the global efficacy question response and the overall satisfaction rate between patients with and without PE or low desire. CONCLUSIONS: The efficacy of sildenafil was negatively affected by an increased duration and severity of ED; however, global efficacy and overall patient satisfaction were not attenuated by PE or low desire.

Ejaculation↗